Institutional investors purchased a net $3.5 million shares of SRPT during the quarter ended December 2012, and now own 69.31% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 1.4 Million shares of Sarepta Therapeutics Inc
PERCEPTIVE ADVISORS LLC Bought 1.4 Million shares of Sarepta Therapeutics Inc